Showing results (191-200 of 305) with videos related to

Sort By:
Pageof 31
Journal of Acquired Immune Deficiency Syndromes (1999)|July 17, 2015
The Kynurenine Pathway of Tryptophan Catabolism and AIDS-Associated Kaposi Sarcoma in AfricaHelen Byakwaga, Peter W Hunt, Miriam Laker-Oketta, et al.
AIDS and Behavior|June 17, 2015
Depression and Oral FTC/TDF Pre-exposure Prophylaxis (PrEP) Among Men and Transgender Women Who Have Sex With Men (MSM/TGW)Patricia A Defechereux, Megha Mehrotra, Albert Y Liu, et al.
AIDS Research and Therapy|April 18, 2018
Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK dataOliver T Stirrup, David T Dunn, Anna Tostevin, et al.
The American Journal of Tropical Medicine and Hygiene|January 9, 2023
The Association between Malnutrition and Malaria Infection in Children under 5 Years in Burkina Faso: A Longitudinal StudyElisabeth Gebreegziabher, Clarisse Dah, Boubacar Coulibaly, et al.
Annals of Internal Medicine|July 3, 2023
Demonstration Project of Long-Acting Antiretroviral Therapy in a Diverse Population of People With HIVMonica Gandhi, Matthew Hickey, Elizabeth Imbert, et al.
AIDS (London, England)|September 26, 2025
Suboptimal ART adherence, undetectable urine tenofovir, and higher C-reactive protein valuesDelaram Ghanooni, Megan J Heise, Kevin Sassaman, et al.
Pharmaceutics|September 23, 2022
Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled AnalysisMaria Garcia-Cremades, Craig W Hendrix, Priya Jayachandran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2022
Characterizing HIV-Preventive, Plasma Tenofovir Concentrations-A Pooled Participant-level Data Analysis From Human Immunodeficiency Virus Preexposure Prophylaxis Clinical TrialsMaria Garcia-Cremades, Katarina Vučićević, Craig W Hendrix, et al.
Open Forum Infectious Diseases|August 18, 2021
Characteristics of High-Titer Convalescent Plasma and Antibody Dynamics After Administration in Patients With Severe Coronavirus Disease 2019Emma D Bainbridge, Priscilla Y Hsue, Jonathan H Esensten, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2016
Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent DosingJose Castillo-Mancilla, Sharon Seifert, Kayla Campbell, et al.
Pageof 31